Navigation Links
Educating the Marketplace Through Collaborations with Patient Advocacy Groups

CHAPEL HILL, N.C., May 18 /PRNewswire/ -- Patient and professional advocacy groups are an integral part of educating the marketplace on new medicines. Effectively collaborating with advocacy groups is fundamental for educating the public on treatment options and is especially critical for socially sensitive conditions/therapies. "Collaborating with Patient Advocacy Groups to Educate the Marketplace" is a 125-page report from Best Practices, LLC that identifies successful tactics and strategies for working with patient advocacy groups and managing relationships.

Download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies:

In addition to providing a road map for effective collaborations with advocacy groups, this Best Practices, LLC research project also examines ideal structures and skill sets for pharma groups that deal with advocacy groups. Fifty-eight advocacy leaders from 43 companies such as Abbott, Wyeth, Genentech, Novartis, Bayer, Amgen, Astellas, Takeda and J&J shared their practices and insights into advocacy group collaborations. More than a dozen organizations participated in deep-dive interviews to provide actionable insights into working with the advocacy world.

Key topics of this report include:

  • Understanding the Advocacy Landscape
  • Managing Advocacy Relationships
  • Managing Relationships with Hostile Groups
  • Structuring High Performance Biopharma Advocacy Groups
  • Using New Technologies
  • Current Trends and Future Directions

Executives, directors and managers at device, pharmaceutical and biotech organizations who work in patient advocacy functions can use this research to compare their group's approaches and tactics for advocacy group interactions against those of leading organizations.

To learn more about Best Practices' other timely research visit: or contact Jeff Zimmer at 919-767-9180 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 46 out of the top 50 pharmaceutical companies. For more information visit:

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UCSF and YouTube Launch Channel Dedicated to Educating the Public About Neurodegenerative Diseases
2. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
3. International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
4. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
5. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
8. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
9. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
10. Marketplace Streamlines M&A Process for Technology Businesses
11. Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1)
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary ... in their initial angel funding process. Now, they are paying it forward to ... early stage investments in the microbiome space. In this, they join other ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
Breaking Biology Technology:
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
Breaking Biology News(10 mins):